Zurich (Switzerland), May 5, 2025 - GENFIT (Nasdaq and Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today ...

One year after the conclusion of their epic battle, OKP discusses whether this will be the last clash of this magnitude.